GPER is required for the age-dependent upregulation of the myocardial endothelin system

Life Sciences

Volumn 159, Issue , 2016, Pages 61-65

  Meyer, Matthias R ^a   Fredette, Natalie C ^a   Sharma, Geetanjali ^a   Barton, Matthias ^b   Prossnitz, Eric R ^a  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Aging; Endothelin converting enzyme; Endothelin receptor; Estrogen receptor; ET 1; GPR30; Heart; Myocardium

Indexed keywords

ENDOTHELIN; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN CONVERTING ENZYME; ENDOTHELIN CONVERTING ENZYME 2; G PROTEIN COUPLED ESTROGEN RECEPTOR; G PROTEIN COUPLED RECEPTOR; MESSENGER RNA; PREPROENDOTHELIN 1; UNCLASSIFIED DRUG; ESTROGEN RECEPTOR; GPER PROTEIN, HUMAN;

AGE; AGED; AGING; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE DELETION; GENE EXPRESSION; HEART LEFT VENTRICLE MUSCLE; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; WILD TYPE MOUSE; ANIMAL; CARDIAC MUSCLE; GENETICS; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY; UPREGULATION;

AGING; ANIMALS; ENDOTHELINS; MALE; MICE; MICE, KNOCKOUT; MYOCARDIUM; RECEPTORS, ESTROGEN; RECEPTORS, G-PROTEIN-COUPLED; UP-REGULATION;

EID: 84959043030     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2016.02.041     Document Type: Article

References (47)

1. [1] Heidenreich, P.A., Albert, N.M., Allen, L.A., Bluemke, D.A., Butler, J., Fonarow, G.C., et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ. Heart Fail. 6:3 (2013), 606–619.
2. [2] Go, A.S., Mozaffarian, D., Roger, V.L., Benjamin, E.J., Berry, J.D., Blaha, M.J., et al. Heart disease and stroke statistics—2014 update: a report from the American Heart Association. Circulation 129:3 (2014), e28–e292.
3. [3] Lakatta, E.G., So! What's aging? Is cardiovascular aging a disease?. J. Mol. Cell. Cardiol. 83 (2015), 1–13.
4. [4] Boyle, A.J., Shih, H., Hwang, J., Ye, J., Lee, B., Zhang, Y., et al. Cardiomyopathy of aging in the mammalian heart is characterized by myocardial hypertrophy, fibrosis and a predisposition towards cardiomyocyte apoptosis and autophagy. Exp. Gerontol. 46:7 (2011), 549–559.
5. [5] Iemitsu, M., Miyauchi, T., Maeda, S., Tanabe, T., Irukayama-Tomobe, Y., Goto, K., et al. Effects of aging and subsequent exercise training on gene expression of endothelin-1 in rat heart. Clin. Sci. (Lond.) 103:Suppl. 48 (2002), 152S–157S.
6. [6] Ceylan-Isik, A.F., Dong, M., Zhang, Y., Dong, F., Turdi, S., Nair, S., et al. Cardiomyocyte-specific deletion of endothelin receptor A rescues aging-associated cardiac hypertrophy and contractile dysfunction: role of autophagy. Basic Res. Cardiol., 108(2), 2013, 335.
7. [7] Wang, X., Guo, Z., Ding, Z., Khaidakov, M., Lin, J., Xu, Z., et al. Endothelin-1 upregulation mediates aging-related cardiac fibrosis. J. Mol. Cell. Cardiol. 80 (2015), 101–109.
8. [8] Guarda, E., Katwa, L.C., Myers, P.R., Tyagi, S.C., Weber, K.T., Effects of endothelins on collagen turnover in cardiac fibroblasts. Cardiovasc. Res. 27:12 (1993), 2130–2134.
9. [9] Ito, H., Hirata, Y., Adachi, S., Tanaka, M., Tsujino, M., Koike, A., et al. Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes. J. Clin. Invest. 92:1 (1993), 398–403.
10. [10] Ishihata, A., Katano, Y., Role of angiotensin II and endothelin-1 receptors in aging-related functional changes in rat cardiovascular system. Ann. N. Y. Acad. Sci. 1067 (2006), 173–181.
11. [11] Hocher, B., George, I., Rebstock, J., Bauch, A., Schwarz, A., Neumayer, H.H., et al. Endothelin system-dependent cardiac remodeling in renovascular hypertension. Hypertension 33:3 (1999), 816–822.
12. [12] Mulder, P., Richard, V., Bouchart, F., Derumeaux, G., Munter, K., Thuillez, C., Selective ETA receptor blockade prevents left ventricular remodeling and deterioration of cardiac function in experimental heart failure. Cardiovasc. Res. 39:3 (1998), 600–608.
13. [13] Sakai, S., Miyauchi, T., Kobayashi, M., Yamaguchi, I., Goto, K., Sugishita, Y., Inhibition of myocardial endothelin pathway improves long-term survival in heart failure. Nature 384:6607 (1996), 353–355.
14. [14] Morawietz, H., Goettsch, W., Szibor, M., Barton, M., Shaw, S., Hakim, K., et al. Increased expression of endothelin-converting enzyme-1 in failing human myocardium. Clin. Sci. (Lond.) 103:Suppl. 48 (2002), 237S–240S.
15. [15] Violin, J.D., Soergel, D.G., Boerrigter, G., Burnett, J.C. Jr., Lark, M.W., GPCR biased ligands as novel heart failure therapeutics. Trends Cardiovasc. Med. 23:7 (2013), 242–249.
16. [16] Feng, Y., Gregor, P., Cloning of a novel member of the G protein-coupled receptor family related to peptide receptors. Biochem. Biophys. Res. Commun. 231:3 (1997), 651–654.
17. [17] Kvingedal, A.M., Smeland, E.B., A novel putative G-protein-coupled receptor expressed in lung, heart and lymphoid tissue. FEBS Lett. 407:1 (1997), 59–62.
18. [18] Owman, C., Blay, P., Nilsson, C., Lolait, S.J., Cloning of human cDNA encoding a novel heptahelix receptor expressed in Burkitt's lymphoma and widely distributed in brain and peripheral tissues. Biochem. Biophys. Res. Commun. 228:2 (1996), 285–292.
19. [19] Revankar, C.M., Cimino, D.F., Sklar, L.A., Arterburn, J.B., Prossnitz, E.R., A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307:5715 (2005), 1625–1630.
20. [20] Thomas, P., Pang, Y., Filardo, E.J., Dong, J., Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 146:2 (2005), 624–632.
21. [21] Prossnitz, E.R., Barton, M., The G-protein-coupled estrogen receptor GPER in health and disease. Nat. Rev. Endocrinol. 7:12 (2011), 715–726.
22. [22] Meyer, M.R., Amann, K., Field, A.S., Hu, C., Hathaway, H.J., Kanagy, N.L., et al. Deletion of G protein-coupled estrogen receptor increases endothelial vasoconstriction. Hypertension 59:2 (2012), 507–512.
23. [23] Meyer, M.R., Field, A.S., Kanagy, N.L., Barton, M., Prossnitz, E.R., GPER regulates endothelin-dependent vascular tone and intracellular calcium. Life Sci. 91 (2012), 623–627.
24. [24] Meyer, M.R., Fredette, N.C., Howard, T.A., Hu, C., Ramesh, C., Daniel, C., et al. G protein-coupled estrogen receptor protects from atherosclerosis. Sci. Rep., 4, 2014, 7564.
25. [25] Jessup, J.A., Lindsey, S.H., Wang, H., Chappell, M.C., Groban, L., Attenuation of salt-induced cardiac remodeling and diastolic dysfunction by the GPER agonist G-1 in female mRen2.Lewis rats. PLoS ONE, 5(11), 2010, e15433.
26. [26] Wang, H., Jessup, J.A., Lin, M.S., Chagas, C., Lindsey, S.H., Groban, L., Activation of GPR30 attenuates diastolic dysfunction and left ventricle remodelling in oophorectomized mRen2.Lewis rats. Cardiovasc. Res. 94:1 (2012), 96–104.
27. [27] De Francesco, E.M., Angelone, T., Pasqua, T., Pupo, M., Cerra, M.C., Maggiolini, M., GPER mediates cardiotropic effects in spontaneously hypertensive rat hearts. PLoS ONE, 8(8), 2013, e69322.
28. [28] Lenhart, P.M., Broselid, S., Barrick, C.J., Leeb-Lundberg, L.M., Caron, K.M., G-protein-coupled receptor 30 interacts with receptor activity-modifying protein 3 and confers sex-dependent cardioprotection. J. Mol. Endocrinol. 51:1 (2013), 191–202.
29. [29] Kang, S., Liu, Y., Sun, D., Zhou, C., Liu, A., Xu, C., et al. Chronic activation of the G protein-coupled receptor 30 with agonist G-1 attenuates heart failure. PLoS ONE, 7(10), 2012, e48185.
30. [30] Deschamps, A.M., Murphy, E., Activation of a novel estrogen receptor, GPER, is cardioprotective in male and female rats. Am. J. Physiol. Heart Circ. Physiol. 297:5 (2009), H1806–H1813.
31. [31] Bopassa, J.C., Eghbali, M., Toro, L., Stefani, E., A novel estrogen receptor GPER inhibits mitochondria permeability transition pore opening and protects the heart against ischemia-reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 298:1 (2010), H16–H23.
32. [32] Lee, T.M., Lin, S.Z., Chang, N.C., Both GPER and membrane oestrogen receptor-alpha activation protect ventricular remodelling in 17beta oestradiol-treated ovariectomized infarcted rats. J. Cell. Mol. Med. 18:12 (2014), 2454–2465.
33. [33] Kabir, M.E., Singh, H., Lu, R., Olde, B., Leeb-Lundberg, L.M., Bopassa, J.C., G protein-coupled estrogen receptor 1 mediates acute estrogen-induced cardioprotection via MEK/ERK/GSK-3beta pathway after ischemia/reperfusion. PLoS ONE, 10(9), 2015, e0135988.
34. [34] Meyer, M.R., Baretella, O., Prossnitz, E.R., Barton, M., Dilation of epicardial coronary arteries by the G protein-coupled estrogen receptor agonists G-1 and ICI 182,780. Pharmacology 86:1 (2010), 58–64.
35. [35] Livak, K.J., Schmittgen, T.D., Analysis of relative gene expression data using real-time quantitative PCR and the 2(− Delta Delta C(T)) Method. Methods 25:4 (2001), 402–408.
36. [36] Vignon-Zellweger, N., Relle, K., Kienlen, E., Alter, M., Seider, P., Sharkovska, J., et al. Endothelin-1 overexpression restores diastolic function in eNOS knockout mice. J. Hypertens. 29:5 (2011), 961–970.
37. [37] Vignon-Zellweger, N., Relle, K., Rahnenfuhrer, J., Schwab, K., Hocher, B., Theuring, F., Endothelin-1 overexpression and endothelial nitric oxide synthase knock-out induce different pathological responses in the heart of male and female mice. Life Sci. 118:2 (2014), 219–225.
38. [38] Emoto, N., Yanagisawa, M., Endothelin-converting enzyme-2 is a membrane-bound, phosphoramidon-sensitive metalloprotease with acidic pH optimum. J. Biol. Chem. 270:25 (1995), 15262–15268.
39. [39] Kaburagi, S., Hasegawa, K., Morimoto, T., Araki, M., Sawamura, T., Masaki, T., et al. The role of endothelin-converting enzyme-1 in the development of alpha1-adrenergic-stimulated hypertrophy in cultured neonatal rat cardiac myocytes. Circulation 99:2 (1999), 292–298.
40. [40] Yanagisawa, H., Hammer, R.E., Richardson, J.A., Emoto, N., Williams, S.C., Takeda, S., et al. Disruption of ECE-1 and ECE-2 reveals a role for endothelin-converting enzyme-2 in murine cardiac development. J. Clin. Invest. 105:10 (2000), 1373–1382.
41. [41] Ortmann, J., Amann, K., Brandes, R.P., Kretzler, M., Munter, K., Parekh, N., et al. Role of podocytes for reversal of glomerulosclerosis and proteinuria in the aging kidney after endothelin inhibition. Hypertension 44:6 (2004), 974–981.
42. [42] Barton, M., Reversal of proteinuric renal disease and the emerging role of endothelin. Nat. Clin. Pract. Nephrol. 4:9 (2008), 490–501.
43. [43] Lindsey, S.H., da Silva, A.S., Silva, M.S., Chappell, M.C., Reduced vasorelaxation to estradiol and G-1 in aged female and adult male rats is associated with GPR30 downregulation. Am. J. Physiol. Endocrinol. Metab. 305:1 (2013), E113–E118.
44. [44] Sharma, G., Hu, C., Brigman, J.L., Zhu, G., Hathaway, H.J., Prossnitz, E.R., GPER deficiency in male mice results in insulin resistance, dyslipidemia, and a proinflammatory state. Endocrinology 154:11 (2013), 4136–4145.
45. [45] Bartella, V., De Francesco, E.M., Perri, M.G., Curcio, R., Dolce, V., Maggiolini, M., et al. The G protein estrogen receptor (GPER) is regulated by endothelin-1 mediated signaling in cancer cells. Cell. Signal. 28:2 (2016), 61–71.
46. [46] Bond, R.A., Ijzerman, A.P., Recent developments in constitutive receptor activity and inverse agonism, and their potential for GPCR drug discovery. Trends Pharmacol. Sci. 27:2 (2006), 92–96.
47. [47] Grohe, C., Kahlert, S., Lobbert, K., Vetter, H., Expression of oestrogen receptor alpha and beta in rat heart: role of local oestrogen synthesis. J. Endocrinol. 156:2 (1998), R1–R7.